Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Tg Therapeutics (TGTX) over the last 16 years, with Dec 2024 value amounting to $23.4 million.

  • Tg Therapeutics' Consolidated Net Income rose 10006.23% to $390.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.5 million, marking a year-over-year increase of 3212.81%. This contributed to the annual value of $23.4 million for FY2024, which is 84.52% up from last year.
  • As of FY2024, Tg Therapeutics' Consolidated Net Income stood at $23.4 million, which was up 84.52% from $12.7 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Consolidated Net Income ranged from a high of $23.4 million in FY2024 and a low of -$348.1 million during FY2021.
  • For the 3-year period, Tg Therapeutics' Consolidated Net Income averaged around -$62.6 million, with its median value being $12.7 million (2023).
  • Per our database at Business Quant, Tg Therapeutics' Consolidated Net Income slumped by 60.56% in 2020 and then soared by 105.66% in 2023.
  • Tg Therapeutics' Consolidated Net Income (Yearly) stood at -$279.9 million in 2020, then decreased by 24.36% to -$348.1 million in 2021, then surged by 35.70% to -$223.8 million in 2022, then skyrocketed by 105.66% to $12.7 million in 2023, then surged by 84.52% to $23.4 million in 2024.